PlumX Metrics
Embed PlumX Metrics

Guidelines on Radioisotope Treatment of Bone Metastases in Prostate Cancer

Clinical Applications of Nuclear Medicine Targeted Therapy, Page: 405-413
2018
  • 0
    Citations
  • 0
    Usage
  • 1
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Book Chapter Description

Radium-223 (Ra-223), strontium-89 (Sr-89), and samarium-153 (Sm-153) are radiopharmaceuticals approved in the United States and elsewhere for the treatment of painful skeletal metastases in select populations (Tables 30.1 and 30.2). The primary aim of this chapter is to provide a cohesive educational review of practice recommendations for these agents using guidelines from professional societies, prescribing information, and published observations.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know